D
4D Molecular Therapeutics, Inc. FDMT
$11.34 $1.3413.40% NASDAQ
Recommendation
Prev Close
$11.34
Volume
6,952
Avg Vol (90D)
1,036,022
Market Cap
$529.61M
Dividend & Yield
--
52-Week Range
$2.24 - $12.34
P/E (TTM)
--
EPS (TTM)
-$3.52
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Peapod Lane Capital LLC Buys 122,684 Shares of 4D Molecular Therapeutics, Inc. $FDMT
10/26/2025 - MarketBeat
4D Molecular Therapeutics (NASDAQ:FDMT) Shares Gap Up - Time to Buy?
10/25/2025 - MarketBeat
4D Molecular Therapeutics (NASDAQ:FDMT) Earns Sell (D-) Rating from Weiss Ratings
10/25/2025 - MarketBeat
12 Hot Stocks to Buy with Huge Upside Potential
10/24/2025 - Insider Monkey
4D Molecular Therapeutics (FDMT) Gets a Buy from Bank of America Securities
10/23/2025 - TipRanks Financial Blog
4D Molecular Therapeutics (FDMT, $10.52) RSI Indicator left the overbought zone on October 22, 2025
10/23/2025 - Tickeron - Stocks
Scott Bizily Sells 1,635 Shares of 4D Molecular Therapeutics (NASDAQ:FDMT) Stock
10/22/2025 - Ticker Report
4D Molecular Therapeutics (NASDAQ:FDMT) Given "Outperform" Rating at Royal Bank Of Canada
10/21/2025 - MarketBeat
RBC Capital Sticks to Their Buy Rating for 4D Molecular Therapeutics (FDMT)
10/21/2025 - TipRanks Financial Blog
4D Molecular Therapeutics (FDMT, $11.27) price may drop as it broke higher Bollinger Band on Oct 20, 2025
10/21/2025 - Tickeron - Stocks
4D Molecular Therapeutics (FDMT, $11.27) RSI Indicator left the overbought zone on October 20, 2025
10/21/2025 - Tickeron - Stocks
Insider Selling: 4D Molecular Therapeutics (NASDAQ:FDMT) Insider Sells 1,635 Shares of Stock
10/21/2025 - MarketBeat
4D Molecular Therapeutics (NASDAQ:FDMT) Hits New 12-Month High - Here's What Happened
10/20/2025 - MarketBeat
4D Molecular Therapeutics (FDMT, $9.84) RSI Indicator left the overbought zone on October 17, 2025
10/18/2025 - Tickeron - Stocks
4DMT Announces New Employment Inducement Grants
10/17/2025 - Globe Newswire
Wall Street Analysts See a 208.52% Upside in 4D Molecular Therapeutics (FDMT): Can the Stock Really Move This High?
10/17/2025 - Zacks Investment Research
Insider Selling: 4D Molecular Therapeutics (NASDAQ:FDMT) Insider Sells $24,080.00 in Stock
10/17/2025 - Ticker Report
4D Molecular Therapeutics (FDMT, $9.97) RSI Indicator left the overbought zone on October 14, 2025
10/15/2025 - Tickeron - Stocks
Scott Bizily Sells 2,408 Shares of 4D Molecular Therapeutics (NASDAQ:FDMT) Stock
10/14/2025 - MarketBeat
4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference
10/14/2025 - Globe Newswire
4DMT Advances 4D-710 to Phase 2 with Additional Funding and Support from the Cystic Fibrosis Foundation
10/13/2025 - Globe Newswire
4D Molecular Therapeutics (FDMT, $8.9) RSI Indicator left the overbought zone on October 10, 2025
10/11/2025 - Tickeron - Stocks
4D Molecular Therapeutics (FDMT, $9.66) RSI Indicator left the overbought zone on October 08, 2025
10/9/2025 - Tickeron - Stocks
4D Molecular Therapeutics (NASDAQ:FDMT) Given Sell (D-) Rating at Weiss Ratings
10/8/2025 - MarketBeat
Analysts Set 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) PT at $30.40
10/6/2025 - Ticker Report
Income Statement
Total Revenue (TTM)
$33.00K
EBITDA (TTM)
-$215.82M
EBIT (TTM)
-$220.33M
Net Income (TTM)
-$196.14M
Balance Sheet
Total Assets (Q)
$473.64M
Total Debt (Q)
$23.08M
Total Liabilities (Q)
$52.75M
Book Value Per Share (Q)
$9.01
Cash Flow
Cash from Operations (TTM)
-$166.39M
Cash from Investing (TTM)
$52.46M
Cash from Financing (TTM)
$2.03M
Net Change in Cash (TTM)
-$111.90M
Filings
Filing Date
Monday, August 11, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Loading...
Beta
1.46
7-Day Total Return
12.39%
30-Day Total Return
66.76%
60-Day Total Return
76.64%
90-Day Total Return
177.26%
Year to Date Total Return
94.51%
1-Year Total Return
39.14%
2-Year Total Return
9.35%
3-Year Total Return
51.20%
5-Year Total Return
--
52-week Low
Apr 09, 2025 - $2.24
52-week High
Oct 24, 2025 - $12.34
Valuation
Market Cap
$529.61M - Small Cap
Enterprise Value
$135.65M
Price/Sales (TTM)
22,680.00
Price/Book (Q)
1.26
Dividends and Shares
Shares Outstanding
55.93
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.4dmoleculartherapeutics.com
Phone Number
510 505 2680
Address
5858 Horton Street
EmeryVille, CA 94608
Country
United States
Year Founded
2013
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform... more
NASDAQ 10/24/2025 4:00PM Eastern Quotes delayed